Frontlight ResearchEarly access
Not yet taking people in NetherlandsPhase 4
Tests whether breathing extra oxygen changes blood flow in the heart and lungs
Tests extra oxygen breathing in adults with heart, lung or blood vessel conditions.
Key facts
- Who runs it
- Stichting Radboud universitair medisch centrum
- Where
- Nijmegen, NetherlandsSee the site
- Trial code
- Registry title
- The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 24 people, planned
- Started
- 1 Oct 2024
- Planned end
- 1 Oct 2025
- Type of study
- Interventional
- Record updated
- 31 October 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are already planned for a heart or lung pressure test or a coronary function test, and who have no blocked heart arteries. It studies how extra oxygen changes blood flow.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Planned for a clinically indicated test for small-vessel heart problems, suspected pulmonary hypertension, or heart transplant or LVAD screening. No obstructive coronary artery disease (50% or less visible narrowing, or a negative FFR/iFR/RFR test).
Main reasons for not taking part
- Estimated glomerular filtration rate below 30 ml/min
- Known COPD GOLD IV
- Known moderate or severe valve disease
- Clinically indicated oxygen treatment
- Pacemaker, active pregnancy or contrast allergy
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Subject ≥18 years of age
- Subject planned for clinically indicated: 1. CFT demonstrating microvascular dysfunction; or 2. RHC (and LHC) for suspected PH; or 3. RHC (and LHC) as a part of HTx or LVAD screening
- No obstructive coronary artery disease (defined as ≤50% visual stenosis and/or negative FFR/iFR/RFR)
- Able and willing to provide informed consent
Who cannot take part
- Clinically indicated treatment with oxygen
- Known history of chronic obstructive pulmonary disease GOLD IV
- Known moderate and severe valvular disease
- Contrast allergy
- Complications during clinically indicated invasive heart catheterization
- Estimated glomerular filtration rate of <30ml/min
- Pacemaker in situ
- Active pregnancy
Where in Netherlands
- Stichting Radboud Universitair Medisch CentrumNijmegen, NetherlandsNot yet recruiting
About the trial
What the trial wants to find out
To objectify the effect of high-concentration (100%) oxygen suppletion on coronary, pulmonary and systemic haemodynamics, and the chronological sequence of these effects
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study
- Plain-language title
- Tests whether breathing extra oxygen changes blood flow in the heart and lungsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 31 October 2024